Myocardial Disease
11
1
3
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
18.2%
2 terminated out of 11 trials
66.7%
-19.8% vs benchmark
18%
2 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
HEAlth Dialogues for Patients With Mental Illness in Primary Care
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With (N)STEMI or Unstable Angina
Deep Learning Super-Resolution Single-Beat CMR
Virtual Reality-Supported Cardiac Rehabilitation: Psychological, Functional, and Physiological Perspectives
Role of Spectral CT in the Diagnosis of Myocarditis/MINOCA in Patients Undergoing cardioCT Investigations for Acute Chest Pain
Impact of Ranolazine on Coronary Microcirculatory Resistance
Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
Cardiovascular Events for a Long Time End of COVID 19 Infection
Effect of Topical Anesthesia on Hemodynamics During the Induction Period in Patients Undergo Cardiac Surgery.
CMR-Lupus Comprehensive Approach by Cardiovascular Magnetic Resonance Tomography
Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy